TRANSTECH PHARMA
Type of company: Drug Discovery
Address: 4170 Mendenhall Oaks Pkwy, High Point, NC 27265
Phone Number: (336) 841-0300
Web site: www.ttpharama.com
Management team:
Adnan Mjalli, Ph.D, President & Chief Executive Officer
Bill Bucella, Senior VP, Legal Affairs
Steve Holcombe, Senior VP & Chief Financial Officer
Stephen Ireland, Senior VP, Business Development
David Ward, MD, Senior VP, Drug Development
Robert Andrews, Ph.D, VP, Chemistry
Bob Rothein, Ph.D, VP, Biology
Reyad Sawafta, Ph.D, VP, Technology
Jane Shen, Pharm.D, VP, Discovery Management
Board Members:
Adnan Mjalli, Ph.D, TransTech Pharma
Eric Rose, MD, Columbia University
Donald Drapkin, MacAndrews & Forbes
Todd Slotkin, MacAndrews & Forbes
Nehad Baker, Baker Trading Company
Investors and Amount Raised: $38 million from MacAndrews & Forbes — original investor; Novo Nordisk & Cephalon, Inc. — strategic partners
Revenues: $5 million since 2001
Year Established: 1999
Number of Employees: 67
